National Drug Code (NDC) Database
Phoenix Pharma SRL
-
NDC:
83555-100
-
Nonproprietary Name:
RHOPALURUS PRINCEPS VENOM
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1 mL
-
Substance:
RHOPALURUS PRINCEPS VENOM
-
Start Marketing Date:
2023-08-27
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Phytex Australia Pty Ltd
-
NDC:
51886-1001
-
Nonproprietary Name:
Castanospermine
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
CASTANOSPERMINE
-
Start Marketing Date:
1994-04-25
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
piCHEM Forschungs-und Entwicklungs GmbH
-
NDC:
72775-984
-
Nonproprietary Name:
OXODOTREOTIDE
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 mg/mg
-
Substance:
OXODOTREOTIDE
-
Start Marketing Date:
2018-12-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Pioneer Life Sciences, LLC
-
NDC:
72090-057
-
Nonproprietary Name:
Simethicone 125 mg
-
Dosage Form:
CAPSULE, LIQUID FILLED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
125 mg/1
-
Substance:
DIMETHICONE
-
Start Marketing Date:
2025-05-23
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Piramal Critical Care Inc
-
NDC:
66794-023
-
Nonproprietary Name:
Sevoflurane
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
1 mL/mL
-
Substance:
SEVOFLURANE
-
Start Marketing Date:
2025-09-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Piramal Healthcare (Canada) Limited
-
NDC:
55679-133
-
Nonproprietary Name:
Brimonidine Tartrate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
BRIMONIDINE TARTRATE
-
Start Marketing Date:
1999-05-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Piramal Pharma Limited
-
NDC:
66112-922
-
Nonproprietary Name:
Labetalol Hydrochloride
-
Dosage Form:
AEROSOL
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
400 mg/1
-
Substance:
LABETALOL HYDROCHLORIDE
-
Start Marketing Date:
2025-12-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
51446-0220
-
Nonproprietary Name:
Docetaxel Anhydrous
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
DOCETAXEL ANHYDROUS
-
Start Marketing Date:
2012-11-20
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
73602-012
-
Nonproprietary Name:
BENZALKONIUM CHLORIDE
-
Dosage Form:
SOLUTION, CONCENTRATE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1 kg/kg
-
Substance:
BENZALKONIUM CHLORIDE
-
Start Marketing Date:
2022-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
24584-1125
-
Nonproprietary Name:
PARECOXIB SODIUM
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
PARECOXIB SODIUM
-
Start Marketing Date:
2016-11-17
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.